Over 500 industry leaders gathered at the Dublin Royal Convention Centre to celebrate excellence in Ireland’s pharma sector ...

Korea’s biotech and pharmaceutical companies are reshaping leadership to sharpen efficiency and competitiveness, with this ...

There’s a reason dengue infections are also called “breakbone fever.” Along with a mild fever, symptoms of the mosquito-borne ...

Bristol-Myers Squibb Company (BMY) recently received a noteworthy “Buy” rating from Tim Anderson of BofA Securities, with a target price of $61, signifying a promising upside from its current trading ...

Shares of Bristol Myers Squibb Co. rallied 3.59% to $54.29 Monday, on what proved to be an all-around grim trading session ...

Futures are trading higher on Monday as we head into the final trading weeks of 2025. All of the major indices were hit hard ...

Bank of America upgrades Bristol Myers to Buy, lifting its price target to $61 on pipeline catalysts, valuation support, and ...

LIB Therapeutics has scored an FDA approval for its cholesterol-lowering, third-generation PCSK9 inhibitor, lerodalcibep-liga ...

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the appointment of Mohamad Tabrizi, M.S., M.B.A., as Senior Vice ...

Every year in biopharma brings its share of grueling defeats, and 2025 was no different, especially for companies targeting ...

In a 2024 review, Richardson and colleagues noted that the immunomodulatory drugs thalidomide, lenalidomide (Revlimid), and ...